Vitiligo is an autoimmune disease in which depigmented skin results from the destruction of melanocytes1, with epidemiological association with other autoimmune diseases2. In previous linkage and genome-wide association studies

[1]  Stephanie A. Santorico,et al.  Autoimmune vitiligo is associated with gain-of-function by a transcriptional regulator that elevates expression of HLA-A*02:01 in vivo , 2016, Proceedings of the National Academy of Sciences.

[2]  Stephanie A. Santorico,et al.  MHC class II super-enhancer increases surface expression of HLA-DR and HLA-DQ and affects cytokine production in autoimmune vitiligo , 2016, Proceedings of the National Academy of Sciences.

[3]  Anushya Muruganujan,et al.  PANTHER version 10: expanded protein families and functions, and analysis tools , 2015, Nucleic Acids Res..

[4]  Andre Altmann,et al.  Re-Annotator: Annotation Pipeline for Microarray Probe Sequences , 2015, PloS one.

[5]  Yakir A Reshef,et al.  Partitioning heritability by functional annotation using genome-wide association summary statistics , 2015, Nature Genetics.

[6]  N. Hayward,et al.  Melanoma genetics , 2015, Journal of Medical Genetics.

[7]  Kaanan P. Shah,et al.  A gene-based association method for mapping traits using reference transcriptome data , 2015, Nature Genetics.

[8]  Göran Andersson,et al.  Multiple Changes of Gene Expression and Function Reveal Genomic and Phenotypic Complexity in SLE-like Disease , 2015, PLoS genetics.

[9]  Nicholas G. Martin,et al.  Genetics of skin color variation in Europeans: genome-wide association studies with functional follow-up , 2015, Human Genetics.

[10]  Michael Benatar,et al.  A genome-wide association study of myasthenia gravis. , 2015, JAMA neurology.

[11]  Mary D. Fortune,et al.  Integration of disease association and eQTL data using a Bayesian colocalisation approach highlights six candidate causal genes in immune-mediated diseases , 2015, Human molecular genetics.

[12]  A. Zwinderman,et al.  Vitiligo-like depigmentation in patients with stage III-IV melanoma receiving immunotherapy and its association with survival: a systematic review and meta-analysis. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  M. Kayser,et al.  Allele-specific transcriptional regulation of IRF4 in melanocytes is mediated by chromatin looping of the intronic rs12203592 enhancer to the IRF4 promoter. , 2015, Human molecular genetics.

[14]  Davide Heller,et al.  STRING v10: protein–protein interaction networks, integrated over the tree of life , 2014, Nucleic Acids Res..

[15]  Aaron J. Sams,et al.  Accounting for eXentricities: Analysis of the X Chromosome in GWAS Reveals X-Linked Genes Implicated in Autoimmune Diseases , 2014, bioRxiv.

[16]  D. Abeni,et al.  Markedly reduced incidence of melanoma and nonmelanoma skin cancer in a nonconcurrent cohort of 10,040 patients with vitiligo. , 2014, Journal of the American Academy of Dermatology.

[17]  Han Xu,et al.  Partitioning heritability of regulatory and cell-type-specific variants across 11 common diseases. , 2014, American journal of human genetics.

[18]  P. Scacheri,et al.  Enhancer variants: evaluating functions in common disease , 2014, Genome Medicine.

[19]  J. Ott,et al.  Genome-wide association scan in north Indians reveals three novel HLA-independent risk loci for ulcerative colitis , 2014, Gut.

[20]  Morgan C. Giddings,et al.  Defining functional DNA elements in the human genome , 2014, Proceedings of the National Academy of Sciences.

[21]  A. Stark,et al.  Transcriptional enhancers: from properties to genome-wide predictions , 2014, Nature Reviews Genetics.

[22]  R. Andrews,et al.  Innate Immune Activity Conditions the Effect of Regulatory Variants upon Monocyte Gene Expression , 2014, Science.

[23]  Nicole Soranzo,et al.  Functional interpretation of non-coding sequence variation: Concepts and challenges , 2013, BioEssays : news and reviews in molecular, cellular and developmental biology.

[24]  C. Wallace,et al.  Bayesian Test for Colocalisation between Pairs of Genetic Association Studies Using Summary Statistics , 2013, PLoS genetics.

[25]  Theresa Guo,et al.  A Polymorphism in IRF4 Affects Human Pigmentation through a Tyrosinase-Dependent MITF/TFAP2A Pathway , 2013, Cell.

[26]  J. Ott,et al.  A genome-wide association study in Han Chinese identifies a susceptibility locus for primary Sjögren's syndrome at 7q11.23 , 2013, Nature Genetics.

[27]  C. Wijmenga,et al.  Mapping of immune-mediated disease genes. , 2013, Annual review of genomics and human genetics.

[28]  R. Spritz,et al.  Risk of Generalized Vitiligo is Associated with the Common 55R-94A-247H Variant Haplotype of GZMB (Encoding Granzyme B) , 2013, The Journal of investigative dermatology.

[29]  P. Sham,et al.  Meta-analysis followed by replication identifies loci in or near CDKN1B, TET3, CD80, DRAM1, and ARID5B as associated with systemic lupus erythematosus in Asians. , 2013, American journal of human genetics.

[30]  Jonathan E. Shoag,et al.  PGC-1 coactivators regulate MITF and the tanning response. , 2013, Molecular cell.

[31]  T. Nijsten,et al.  Decreased risk of melanoma and nonmelanoma skin cancer in patients with vitiligo: a survey among 1307 patients and their partners , 2013, The British journal of dermatology.

[32]  Q. Shu,et al.  Identification of a susceptibility locus in STAT4 for Behçet's disease in Han Chinese in a genome-wide association study. , 2012, Arthritis and rheumatism.

[33]  S. Bae,et al.  Genome-wide pathway analysis of genome-wide association studies on systemic lupus erythematosus and rheumatoid arthritis , 2012, Molecular Biology Reports.

[34]  T. Akiyama,et al.  RANKL-RANK interaction in immune regulatory systems. , 2012, World journal of orthopedics.

[35]  R. Spritz,et al.  Next-generation DNA re-sequencing identifies common variants of TYR and HLA-A that modulate the risk of generalized vitiligo via antigen presentation. , 2012, The Journal of investigative dermatology.

[36]  Jo Lambert,et al.  Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo , 2012, Nature Genetics.

[37]  Nicholas Eriksson,et al.  Novel Associations for Hypothyroidism Include Known Autoimmune Risk Loci , 2011, PloS one.

[38]  L. Liang,et al.  A genome-wide association study identifies two new risk loci for Graves' disease , 2011, Nature Genetics.

[39]  John A. Todd,et al.  Genome-Wide Association Analysis of Autoantibody Positivity in Type 1 Diabetes Cases , 2011, PLoS genetics.

[40]  Jaak Vilo,et al.  g:Profiler—a web server for functional interpretation of gene lists (2011 update) , 2011, Nucleic Acids Res..

[41]  Christian Gieger,et al.  Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci , 2011, Nature Genetics.

[42]  Tariq Ahmad,et al.  Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci , 2010, Nature Genetics.

[43]  R. Spritz.  The genetics of generalized vitiligo: autoimmune pathways and an inverse relationship with malignant melanoma , 2010, Genome Medicine.

[44]  L. Weiss,et al.  MUM1/IRF4: A Review , 2010, Applied immunohistochemistry & molecular morphology : AIMM.

[45]  Annette Lee,et al.  Genome-wide association study in alopecia areata implicates both innate and adaptive immunity , 2010, Nature.

[46]  Sheri L. Riccardi,et al.  Common variants in FOXP1 are associated with generalized vitiligo , 2010, Nature Genetics.

[47]  Jo Lambert,et al.  Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo. , 2010, The New England journal of medicine.

[48]  N. Cox,et al.  Trait-Associated SNPs Are More Likely to Be eQTLs: Annotation to Enhance Discovery from GWAS , 2010, PLoS genetics.

[49]  P. Deloukas,et al.  Multiple common variants for celiac disease influencing immune gene expression , 2010, Nature Genetics.

[50]  Ann B. Lee,et al.  Discovering genetic ancestry using spectral graph theory , 2009, Genetic epidemiology.

[51]  G. Girolomoni,et al.  The Role of Innate Immunity in Vitiligo , 2010 .

[52]  Ying Wang,et al.  Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus , 2009, Nature Genetics.

[53]  R. Sen,et al.  Faculty Opinions recommendation of REL, encoding a member of the NF-kappaB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis. , 2009 .

[54]  Peter Kraft,et al.  Genome-wide association study of tanning phenotype in a population of European ancestry. , 2009, The Journal of investigative dermatology.

[55]  Michael C. Ostrowski,et al.  Eos Mediates Foxp3-Dependent Gene Silencing in CD4+ Regulatory T Cells , 2009, Science.

[56]  D. Xing,et al.  BimL directly neutralizes Bcl‐xL to promote Bax activation during UV‐induced apoptosis , 2009, FEBS letters.

[57]  Larry W. Moreland,et al.  REL, a member of the NF-κB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis , 2009, Nature Genetics.

[58]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[59]  Sheri L. Riccardi,et al.  NALP1 in vitiligo-associated multiple autoimmune disease. , 2007, The New England journal of medicine.

[60]  M. Picardo,et al.  The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. , 2007, Pigment cell research.

[61]  L. Chin,et al.  Bcl2L12 inhibits post-mitochondrial apoptosis signaling in glioblastoma. , 2007, Genes & development.

[62]  D. Reich,et al.  Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.

[63]  R. Spritz,et al.  Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo. , 2005, Pigment cell research.

[64]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[65]  R. Spritz,et al.  Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. , 2003, Pigment cell research.

[66]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[67]  R. M. van den Wijngaard,et al.  A symbiotic concept of autoimmunity and tumour immunity: lessons from vitiligo. , 2001, Trends in immunology.

[68]  G. Barsh,et al.  Interaction of Agouti protein with the melanocortin 1 receptor in vitro and in vivo. , 1998, Genes & development.

[69]  L. McDonald,et al.  A Cytosolic Granzyme B Inhibitor Related to the Viral Apoptotic Regulator Cytokine Response Modifier A Is Present in Cytotoxic Lymphocytes* , 1996, The Journal of Biological Chemistry.

[70]  P. Linsley,et al.  Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. , 1994, Immunity.